Oxidative stress has been implicated as an important etiologic factor in atherosclerosis and vascular dysfunction. Antioxidants may inhibit atherogenesis and improve vascular function by two different mechanisms. First, lipld-soluble antioxidants present in low-density lipoprotein (LDL), Including α-tocopherol, and water-soluble antioxidants present in the extracellular fluid of the arterial wall, including ascorbic acid (vitamin C), inhibit LDL oxidation through an LDL-specific antioxidant action. Second, antioxidants present in the cells of the vascular wall decrease cellular production and release of reactive oxygen species (ROS), inhibit endothelial activation (i.e., expression of adhesion molecules and monocyte chemoattractants), and improve the biologic activity of endothelium-derived nitric oxide (EDNO) through a cell- or tissue-specific antioxidant action. α-Tocopherol and a number of thiol antioxidants have been shown to decrease adhesion molecule expression and monocyte-endothelial Interactions. Vitamin C has been demonstrated to potentiate EDNO activity and normalize vascular function in patients with coronary artery disease and associated risk factors, including hypercholesterolemia, hyperhomocysteinemia, hypertension, diabetes, and smoking.
Get full access to this article
View all access options for this article.
References
1.
American Heart Association.1999 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 1998.
2.
SchwartzCJ, ValenteAJ. The pathogenesis of atherosclerosis. In: FreiB, Ed. Natural Antioxidants in Human Health and Disease. San Diego: Academic Press, pp 287–302, 1994.
3.
RossR.Rous-Whipple Award Lecture. Atherosclerosis: A defense mechanism gone awry. Am J Pathol143: 987–1002, 1993.
4.
De CaterinaR, LibbyP, PengHB, ThannickalVJ, RajavashisthTB, GimbroneMAJr.Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest96: 60–68, 1995.
5.
RajavashisthTB, AndalibiA, TerritoMC, BerlinerJA, NavabM, FogelmanAM, LusisAJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature344: 254–257, 1990.
6.
ClintonS, UnderwoodR, ShermanM, KufeD, LibbyP.Macrophage colony stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Path140: 301–316, 1992.
7.
CybulskyMI, GimbroneMAJr.Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science251: 788–791, 1991.
O'brienKD, AllenMD, McDonaldTO, ChaitA, HarlanJM, FishbeinD, McCartyJ, FergusonM, HudkinsK, BenjaminCD. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest92: 945–951, 1993.
10.
DuplaaC, CouffinhalT, LabatL, MoreauC, Petit-JeanME, DoutreMS, LamaziereJM, BonnetJ.Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions. Atherosclerosis121: 253–266, 1996.
11.
SchwartzD, AndalibiA, Chaverri-AlmadaL, BerlinerJA, KirchgessnerT, FangZT, Tekamp-OlsonP, LusisAJ, GallegosC, FogelmanAM. Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. J Clin Invest94: 1968–1973, 1994.
SteinbergD, ParthasarathyS, CarewTE, KhooJC, WitztumJL. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med320: 915–924, 1989.
14.
EsterbauerH, GebickiJ, PuhlH, JurgensG.The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med13: 341–390, 1992.
15.
HeineckeJW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low-density lipoprotein hypothesis. Atherosclerosis141: 1–15, 1998.
16.
McCallMR, FreiB.Mechanism(s) of LDL oxidation. In: KeaneyJFJr., Ed. Oxidative Stress and Vascular Disease. Norwell, MA: Kluwer Academic Press, in press.
17.
GoldsteinJL, HoYK, BasuSK, BrownMS. Binding site on macrophages that mediates uptake and degradation of acetylated low-density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A76: 333–337, 1979.
18.
HenriksenT, MahoneyEM, SteinbergD.Enhanced macrophage degradation of low-density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low-density lipoproteins. Proc Natl Acad Sci U S A78: 6499–6503, 1981.
19.
DaughertyA, DunnJL, RateriDL, HeineckeJW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest94: 437–444, 1994.
20.
HazellU, ArnoldL, FlowersD, WaegG, MalleE, StockerR.Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest97: 1535–1544, 1996.
21.
HazellLJ, StockerR.α-Tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 of low-density lipoprotein. FEBS Lett414: 541–544, 1997.
22.
NavabM, ImesSS, HamaSY, HoughGP, RossLA, BorkRW, ValenteAJ, BerlinerJA, DrinkwaterDC, LaksH. Monocyte transmigration induced by modification of low-density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein-1 synthesis and is abolished by high-density lipoprotein. J Clin Invest88: 2039–2046, 1991.
FrostegardJ, HaegerstrandA, GidlundM, NilssonJ.Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis90: 119–126, 1991.
27.
LehrHA, HubnerC, FinckhB, AngermullerS, NolteD, BeisiegelU, KohlschutterA, MessmerK.Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low-density lipoprotein in hamsters. J Clin Invest88: 9–14, 1991.
28.
KimJA, TerritoMC, WaynerE, CarlosTM, ParhamiF, SmithCW, HaberlandME, FogelmanAM, BerlinerJA. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler Thromb Vase Biol14: 427–433, 1994.
29.
SugiyamaS, KugiyamaK, OhgushiM, FujimotoK, YasueH.Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries: Role of protein kinase C. Circ Res74: 565–575, 1994.
30.
CominaciniL, GarbinU, PasiniAF, DavoliA, CampagnolaM, ContessiGB, PastorinoAM, Lo CascioV.Antioxidants inhibit the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radic Biol Med22: 117–127, 1997.
31.
VoraDK, FangZT, LivaSM, TynerTR, ParhamiF, WatsonAD, DrakeTA, TerritoMC, BerlinerJA. Induction of P-selectin by oxidized lipoproteins: Separate effects on synthesis and surface expression. Circ Res80: 810–818, 1997.
32.
DiazMN, FretB, VitaJA, KeaneyJFJr.Antioxidants and atherosclerotic heart disease. N Engl J Med337: 408–416, 1997.
33.
StockerR, FreiB.Endogenous antioxidant defenses in human blood plasma. In: SiesH, Ed. Oxidative Stress: Oxidants and Antioxidants. London: Academic Press, pp 213–243, 1991.
34.
JonesDP, CarlsonJL, SamiecPS, SternbergPJr.Glutathione measurement in human plasma: Evaluation of sample collection, storage, and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin Chim Acta275: 175–184, 1998.
35.
EsterbauerH, Dieber-RothenederM, StrieglG, WaegG.Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr53:314S–321S, 1991.
36.
LynchSM, MorrowJD, RobertsLJ, FreiB.Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low-density lipoprotein exposed to oxidative stress in vitro. J Clin Invest93:998–1004, 1994.
37.
GokceN, FreiB.Basic research in antioxidant inhibition of steps in atherogenesis. J Cardiovasc Risk3: 352–357, 1996.
FreiB, StockerR, AmesBN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A85: 9748–9752, 1988.
40.
FreiB, ForteTM, AmesBN, CrossCE. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma: Protective effects of ascorbic acid. Biochem J277: 133–138, 1991.
41.
FreiB, StockerR, AmesBN. Small molecule antioxidant defenses in human extracellular fluids. In: ScandaliosJ, Ed. The Molecular Biology of Free Radical Scavenging Systems. Cold Spring Harbor, NY: CSH Laboratory Press, pp 23–45, 1992.
42.
FreiB, EnglandL, AmesBN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A86: 6377–6381, 1989.
43.
BergerTM, PolidoriMC, DabbaghA, EvansPJ, HalliwellB, MorrowJD, RobertsLJII, FreiB.Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem272: 15656–15660, 1997.
44.
RetskyKL, FreemanMW, FreiB.Ascorbic acid oxidation product (s) protect human low-density lipoprotein against atherogenic modification: Anti- rather than pro-oxidant activity of vitamin C in the presence of transition metal ions. J Biol Chem268: 1304–1309, 1993.
45.
RetskyKL, FreiB.Vitamin C prevents metal ion-dependanl initiation and propagation of lipid peroxidation in human low-density lipoprotein. Biochim Biophys Acta1257: 279–287, 1995.
46.
HattaA, FreiB.Oxidative modification and antioxidant protection of human low-density lipoprotein at high and low oxygen partial pressures. J Lipid Res36: 2383–2393, 1995.
47.
RetskyKL, ChenK, ZeindJ, FreiB.Inhibition of copper-induced LDL oxidation by vitamin C is associated with decreased copper binding to LDL and 2-oxo-histidine formation. Free Radic Biol Med26: 90–98, 1999.
48.
StockerR, BowryVW, FreiB.Ubiquinol-10 protects human low-density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci U S A88: 1646–1650, 1991.
49.
MartinA, FreiB.Both intra- and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells. Arterioscler Thromb Vase Biol17: 1583–1590, 1997.
50.
LynchSM, GazianoMJ, FreiB.Ascorbic acid and atherosclerotic-cardiovascular disease. In: HarrisJR, Ed. Ascorbic Acid: Biochemistry and Biomedical Cell Biology. New York: Plenum Press, pp 331–367, 1996.
51.
GazianoMJ, HattaA, FlynnM, JohnsonEJ, KrinskyNI, RidkerPM, HennekensCH, FreiB.Supplementation with β-carotene in vivo and in vitro does not inhibit low-density lipoprotein oxidation. Atherosclerosis112: 187–195, 1995.
52.
JialalI, FullerCJ, HuetBA. The effect of α-tocopherol supplementation on LDL oxidation: A dose-response study. Arterioscler Thromb Vase Biol15: 190–197, 1995.
53.
SimonsLA, Von KonigsmarkM, BalasubramaniamS.What dose of vitamin E is required to reduce susceptibility of LDL to oxidation?Aust N Z J Med26: 496–503, 1996.
54.
PrincenHMG, van DuyvenvoordeW, BuytenhekR, van der LaarseA, van PoppelG, Gevers LeuvenJA, van HinsberghVWM.Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vase Biol15: 325–333, 1995.
55.
BowryVW, StockerR.Tocopherol-mediated peroxidation: The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc115: 6029–6040, 1993.
56.
ParthasarathyS.Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low-density lipoprotein: Use of a new water-soluble probucol derivative. J Clin Invest89: 1618–1621, 1992.
57.
IslamKN, DevarajS, JialalI.α-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation98: 2255–2261, 1998.
58.
DevarajS, JialalI.α-Tocopherol decreases interleukin-1β release from activated human monocytes by inhibition of 5-lipoxygenase. Arterioscler Thromb Vase Biol19: 1125–1133, 1999.
59.
MaruiN, OffermannMK, SwerlickR, KunschC, RosenCA, AhmadM, AlexanderRW, MedfordRM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest92: 1866–1874, 1993.
60.
CollinsT.Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest68: 499–508, 1993.
61.
WeberC, ErlW, PietschA, StrobelM, Ziegler-HeitbrockHW, WeberPC. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb Vase Biol14: 1665–1673, 1994.
62.
FaruqiR, de la MotteC, DiCorletoPE. α-Tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest94: 592–600, 1994.
63.
FaruqiRM, PopticEJ, FaruqiTR, de la MotteC, DiCorletoPE. Distinct mechanisms for N-acetylcysteine inhibition of cytokine-induced E-selectin and VCAM-1 expression. Am J Physiol273: H817–H826, 1997.
64.
MartinWJI.Neutrophils kill pulmonary endothelial cells by a hydrogen peroxide-dependent pathway. Am Rev Respir Dis130: 209–213, 1984.
65.
JonasE, DwengerA, HagerA.In vitro effect of ascorbic acid on neutrophil-endothelial cell interaction. J Biolumin Chemilumin8: 15–20, 1993.
66.
LehrHA, FreiB, ArforsKE. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci U S A91: 7688–7692, 1994.
67.
LehrHA, FreiB, OlofssonAM, CarewTE, ArforsKE. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation91: 1525–1532, 1995.
68.
WeberC, WolfgangE, WeberK, WeberPC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation93: 1488–1492, 1996.
69.
LehrHA, OlofssonAM, CarewTE, VajkoczyP, von AndrianUH, HubnerC, BerndtMC, SteinbergD, MessmerK, ArforsKE. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest71: 380–386, 1994.
70.
AdamsMR, JessupW, CelermajerDS. Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: Reversibility with oral 1-arginine but not vitamin C. J Am Coll Cardiol29: 491–497. 1997.
71.
Negre-SalvayreA, AlomarY, TrolyM, SalvayreR.Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways. Biochim Biophys Acta1096: 291–300, 1991.
72.
ReidVC, MitchinsonMJ. Toxicity of oxidised low-density lipoprotein towards mouse peritoneal macrophages in vitro. Atherosclerosis98:17–24, 1993.
73.
SuttorpN, ToepferW, RokaL.Antioxidant defense mechanisms of endothelial cells: Glutathione redox cycle versus catalase. Am J Physiol251: C671–C680, 1986.
74.
AndreoliSP, MallettCP, BergsteinJM. Role of glutathione in protecting endothelial cells against hydrogen peroxide oxidant injury. J Lab Clin Med108: 190–198, 1986.
75.
KuzuyaM, NaitoM, FunakiC, HayashiT, AsaiK, KuzuyaF.Protective role of intracellular glutathione against oxidized low-density lipoprotein in cultured endothelial cells. Biochem Biophys Res Commun163: 1466–1472, 1989.
76.
ThomasJP, GeigerPG, GirottiAW. Lethal damage to endothelial cells by oxidized low-density lipoprotein: Role of selenoperoxidases in cytoprotection against lipid hydroperoxide- and iron-mediated reactions. J Lipid Res34: 479–490, 1993.
77.
KanekoT, KajiK, MatsuoM.Protective effect of lipophilic derivatives of ascorbic acid on lipid peroxide-induced endothelial injury. Arch Biochem Biophys304: 176–180, 1993.
78.
CookeJP, DzauVJ. Nitric oxide synthase: Role in the genesis of vascular disease. Annu Rev Med48: 489–509, 1997.
79.
GryglewskiRJ, PalmerRM, MoncadaS.Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature320: 454–456, 1986.
MyersPR, WrightTF, TannerMA, OstlundREJr.The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium. J Lab Clin Med124: 672–683, 1994.
82.
KugiyamaK, KernsSA, MorrisettJD, RobertsR, HenryPD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature344: 160–162, 1990.
GokceN, KeaneyJFJr.Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation99: 3234–3240, 1999.
85.
ItoK, AkitaH, KanazawaK, YamadaS, TerashimaM, MatsudaY, YokoyamaM.Comparison of effects of ascorbic acid on endothelium-dependent vasodilation in patients with chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy versus patients with effort angina pectoris secondary to coronary artery disease. Am J Cardiol82: 762–767, 1998.
86.
KugiyamaK, MotoyamaT, HirashimaO, OhgushiM, SoejimaH, MisumiK, KawanoH, MiyaoY, YoshimuraM, OgawaH, MatsumuraT, SugiyamaS, YasueH.Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol32: 103–109, 1998.
87.
HornigB, ArakawaN, KohlerC, DrexlerH.Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation97: 363–368, 1998.
88.
TingHH, TimimiFK, HaleyEA, RoddyM, GanzP, CreagerMA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation95: 2617–2622, 1997.
89.
SolzbachU, HornigB, JeserichM, JustH.Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation96: 1513–1519, 1997.
90.
TaddeiS, VirdisA, GhiadoniL, MagagnaA, SalvettiA.Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation97: 2222–2229, 1998.
91.
ChambersJC, McGregorA, Jean-MarieJ, ObeidOA, KoonerJS. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: An effect reversible with vitamin C therapy. Circulation99: 1156–1160, 1999.
92.
HeitzerT, JustH, MunzelT.Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation94: 6–9, 1996.
93.
MotoyamaT, KawanoH, KugiyamaK. Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: Effect of vitamin C. Am J Physiol273:H1644–H1650, 1997.
94.
TingHH, TimimiFK, BolesKS, CreagerSJ, GanzP, CreagerMA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest97: 22–28, 1996.
95.
TimimiFK, TingHH, HaleyEA, RoddyM, GanzP, CreagerMA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol31: 552–557, 1998.
96.
PlotnickGD, CorrettiMC, VogelRA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA278: 1682–1686, 1997.
97.
GreenD, O'driscollG, RankinJM, MaioranaAJ, TaylorRR. Beneficial effect of vitamin E administration on nitric oxide function in subjects with hypercholesterolaemia. Clin Sci (Colch)95: 361–367, 1998.
98.
MotoyamaT, KawanoH, KugiyamaK, HirashimaO, OhgushiM, TsunodaR, MoriyamaY, MiyaoY, YoshimuraM, OgawaH, YasueH.Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol32: 1672–1679, 1998.
99.
HeitzerT, Yla HerttualaS, WildE, LuomaJ, DrexlerH.Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking, or both. J Am Coll Cardiol33: 499–505, 1999.
100.
SimonsLA, von KonigsmarkM, SimonsJ, StockerR, CelermajerDS. Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults. Atherosclerosis143: 193–199, 1999.
101.
JacksonTS, XuA, VitaJA, KeaneyJFJr.Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res83: 916–922, 1998.
102.
LevineM, Conry-CantilenaC, WangY, WelchRW, WashkoPW, DhariwalKR, ParkJB, LazarevA, GraumlichJF, KingJ, CantilenaLR. Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A93: 3704–3709, 1996.
103.
MeisterA.Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem269: 9397–9400, 1994.
